FDA designates NeuRx Diaphragm Pacing System as HUD device for ALS patients
Links shared publicly online about this topic.
- 810total visits
FDA designates NeuRx Diaphragm Pacing System as HUD device for ALS patients
View full resource at news-medical.net
Tags: ALS, Lung, Drug, HUD, FDA, Biomed
Most Recently Shared on October 11, 2010 at 5:50 am By:
FDA designates NeuRx Diaphragm Pacing System as HUD device for ALS patients: Synapse Biomedical Inc. announces tod... http://bit.ly/dfOHGG
Synapse Biomedical Receives FDA Humanitarian Use Device Designation For Amyotrophic Lateral Sclerosis (ALS) - QualityPoint Technologies
qualitypointtech.net — “Synapse Biomedical Inc. announces that they have received the U.S. Food and Drug Administration (FDA) designation of the NeuRx Diaphragm Pacing System (DPS)" as a Humanitarian Use Device (HUD) for amyotrophic lateral sclerosis (ALS) patients with a stimulatable diaphragm who are experiencing chronic hypoventilation and has now submitted for Humanitarian Device Exemption (HDE) approval...” View full resource at qualitypointtech.net
Most Recently Shared on October 9, 2010 at 4:12 pm By:
Synapse Biomedical Receives FDA Humanitarian Use Device Designation For Amyotrophic Lateral Sclerosis (ALS): Synap... http://bit.ly/9q796K
Advertisement
